There are 3397 resources available
How to overcome IO resistance: New approaches
Presenter: Edward Garon
Session: Open questions in immunotherapy for advanced NSCLC: Duration of IO, combinations and rechallenge
Resources:
Slides
Webcast
Evolving diagnostics in gastroesophageal cancer
Presenter: Nicole van Grieken
Session: Upper GI cancers: From bench to bedside
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast
Should effectiveness data be taken into consideration for drug appraisal by regulatory authorities?
Presenter: John Cairns
Session: Bridging the Efficacy-Effectiveness (E-E) gap for cancer therapies
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Do we enter a new era of oncology with big data and artificial intelligence?
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Basic Science and Translational research
Resources:
Webcast
377O - A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB) -01, -02, and -03
Presenter: Sara Hurvitz
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
505MO - A phase 0/Ib study of AZD1390 plus radiotherapy in recurrent glioblastoma patients
Presenter: Nader Sanai
Session: Mini oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
CN76 - Consensus views on research priorities for cancer survivorship in older adulthood: A Delphi study
Presenter: Amanda Drury
Session: EONS16: Health promotion, prevention and screening
Resources:
Abstract
860MO - MRG003: A novel EGFR-targeted antibody-drug conjugant (ADC) for recurrent/metastatic nasopharyngeal carcinoma
Presenter: Fei Han
Session: Mini oral session - Head and neck cancer
Resources:
Abstract
Slides
Webcast